Off-target binding of [124/125I]IPPI to MAO-A or MAO-B would not be a concern because of a lack of effect of clorgyline (MAO-A) or deprenyl (MAO-B) on [125I]IPPI binding in the AD brains [14]. The gene discussed is MAOA; the disease is Alzheimer disease.